Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| REGENXBIO Inc.RGNX · Entity 2211 | Director | May 29, 2026 | June 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
REGENXBIO Inc.
Report date May 29, 2026 · Filed June 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 28,861 |
Reported balance
After 2026-05-29 transaction · row 1
1 source rowRow 1 · 2026-05-29 · Grant · Acquired 9,807 · Balance 28,861 F1: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the recipient to the Issuer. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.01 · Expires 2036-05-29 | Direct | 46,600 |
Reported balance
After 2026-05-29 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-05-29 · Grant · Acquired 46,600 · Balance 46,600 F3: The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer. |
| Common StockSEC Table I · non-derivative | IndirectBy AMF Family Gift Trust LLC | 722,485 |
Reported balance
Holding disclosure · report date 2026-05-29 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 722,485 F2: The reporting person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose |
| Common StockSEC Table I · non-derivative | IndirectBy AMF Gift Trust LLC | 315,000 |
Reported balance
Holding disclosure · report date 2026-05-29 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 315,000 F2: The reporting person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose |
| Common StockSEC Table I · non-derivative | IndirectBy HBF Gift Trust LLC | 315,000 |
Reported balance
Holding disclosure · report date 2026-05-29 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 315,000 F2: The reporting person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose |
| Common StockSEC Table I · non-derivative | IndirectBy Quaker Gray LLC | 1,529,981 |
Reported balance
Holding disclosure · report date 2026-05-29 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 1,529,981 F2: The reporting person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the recipient to the Issuer.
F2: The reporting person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose
F3: The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 29, 2026 Filed Jun 2, 2026 21:15 UTC | REGENXBIO Inc. RGNX · Entity 2211 | GrantStock Options (Right to Buy) · Derivative | 46,600 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0001652936-26-000001 · primarydocument.xml · derivative · entry 6 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,600 Underlying: Common Stock · 46,600 shares Expires 2036-05-29 F3 · derivative.exercise_date: The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 21:15 UTC | REGENXBIO Inc. RGNX · Entity 2211 | GrantCommon Stock | 9,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001652936-26-000001 · primarydocument.xml · nonDerivative · entry 1 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,861 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:37 UTC | REGENXBIO Inc. RGNX · Entity 2211 | GrantStock Options (Right to Buy) · Derivative | 39,815 | $0.00 Strike: $8.85 | $0.00 |
DisclosureSEC source: 0001562180-25-004355 · primarydocument.xml · derivative · entry 6 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,815 Underlying: Common Stock · 39,815 shares Expires 2035-05-30 F3 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 30, 2025 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:37 UTC | REGENXBIO Inc. RGNX · Entity 2211 | GrantCommon Stock | 7,768 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004355 · primarydocument.xml · nonDerivative · entry 1 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,054 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:41 UTC | REGENXBIO Inc. RGNX · Entity 2211 | GrantStock Options (Right to Buy) · Derivative | 24,454 | $0.00 Strike: $14.35 | $0.00 |
DisclosureSEC source: 0001562180-24-004651 · primarydocument.xml · derivative · entry 6 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,454 Underlying: Common Stock · 24,454 shares Expires 2034-05-31 F3 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 31, 2024 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:41 UTC | REGENXBIO Inc. RGNX · Entity 2211 | GrantCommon Stock | 4,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004651 · primarydocument.xml · nonDerivative · entry 1 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,286 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2025 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 21:14 UTC | REGENXBIO Inc. RGNX · Entity 2211 | GrantStock Options (Right to Buy) · Derivative | 17,892 | $0.00 Strike: $19.72 | $0.00 |
DisclosureSEC source: 0001562180-23-004896 · primarydocument.xml · derivative · entry 6 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,892 Underlying: Common Stock · 17,892 shares Expires 2033-06-02 F3 · derivative.exercise_date: The option will vest in 12 equal monthly installments following June 2, 2023 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 21:14 UTC | REGENXBIO Inc. RGNX · Entity 2211 | GrantCommon Stock | 3,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004896 · primarydocument.xml · nonDerivative · entry 1 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,496 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2024 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 20:17 UTC | REGENXBIO Inc. RGNX · Entity 2211 | GrantStock Option (Right to Buy) · Derivative | 15,324 | $0.00 Strike: $22.84 | $0.00 |
DisclosureSEC source: 0001562180-22-004875 · primarydocument.xml · derivative · entry 2 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,324 Underlying: Common Stock · 15,324 shares Expires 2032-06-03 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following June 3, 2022 while the optionee provides continuous service to the Issuer. Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 20:17 UTC | REGENXBIO Inc. RGNX · Entity 2211 | GrantCommon Stock | 3,010 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004875 · primarydocument.xml · nonDerivative · entry 1 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,010 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2023 while the recipient provides continuous service to the Issuer. Read SEC document |
| December 23, 2021 Filed Dec 27, 2021 21:16 UTC | REGENXBIO Inc. RGNX · Entity 2211 | SaleCommon Stock | 6,323 | $35.85 | $226,663.74 |
DisclosureSEC source: 0001562180-21-007876 · primarydocument.xml · nonDerivative · entry 3 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Quaker Gray LLC Disclosed balance after: 1,529,981 F4 · price: This transaction was executed in multiple trades at prices ranging from $35.75 to $36.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: The reporting person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 23, 2021 Filed Dec 27, 2021 21:16 UTC | REGENXBIO Inc. RGNX · Entity 2211 | SaleCommon Stock | 44,908 | $34.92 | $1,568,120.00 |
DisclosureSEC source: 0001562180-21-007876 · primarydocument.xml · nonDerivative · entry 2 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Quaker Gray LLC Disclosed balance after: 1,536,304 F3 · price: This transaction was executed in multiple trades at prices ranging from $34.75 to $35.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: The reporting person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 22, 2021 Filed Dec 27, 2021 21:16 UTC | REGENXBIO Inc. RGNX · Entity 2211 | SaleCommon Stock | 61,638 | $34.40 | $2,120,575.26 |
DisclosureSEC source: 0001562180-21-007876 · primarydocument.xml · nonDerivative · entry 1 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Quaker Gray LLC Disclosed balance after: 1,581,212 F1 · price: This transaction was executed in multiple trades at prices ranging from $34.01 to $34.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: The reporting person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 20:15 UTC | REGENXBIO Inc. RGNX · Entity 2211 | SaleCommon Stock | 48,233 | $45.04 | $2,172,322.68 |
DisclosureSEC source: 0000899243-21-036773 · doc4.xml · nonDerivative · entry 1 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By DING LLC Disclosed balance after: 1,364,309 F1 · price: This transaction was executed in multiple trades at prices ranging from $45.00 to $45.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: The reporting person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 20:17 UTC | REGENXBIO Inc. RGNX · Entity 2211 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $35.52 | $0.00 |
DisclosureSEC source: 0001562180-21-004126 · primarydocument.xml · derivative · entry 1 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-06-04 F1 · derivative.exercise_date: The option will vest in 12 equal monthly installments following June 4, 2021. Read SEC document |
| August 06, 2020 Filed Sep 18, 2020 20:37 UTC | REGENXBIO Inc. RGNX · Entity 2211 | GiftCommon Stock | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-025725 · doc4.xml · nonDerivative · entry 4 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By The Harriette B. Fox Revocable Trust Disclosed balance after: 315,000 F2 · ownership.nature: This transaction involved a gift of shares of common stock held by The Allan M. Fox Revocable Trust to The Harriette B. Fox Revocable Trust, a revocable trust established for the benefit of the reporting person's spouse. The shares subsequently were transferred to HBF Gift Trust LLC on August 6, 2020. The reporting person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| August 06, 2020 Filed Sep 18, 2020 20:37 UTC | REGENXBIO Inc. RGNX · Entity 2211 | GiftCommon Stock | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-025725 · doc4.xml · nonDerivative · entry 3 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By The Allan M. Fox Revocable Trust Disclosed balance after: 1,324,110 F1 · ownership.nature: At the time of the transaction, the reporting person was a trustee of The Allan M. Fox Revocable Trust, which was the direct beneficial owner of the shares of the Issuer's common stock. The reporting person disclaims beneficial ownership of such shares. Such shares are now held by DING LLC. Read SEC document |
| July 27, 2020 Filed Sep 18, 2020 20:37 UTC | REGENXBIO Inc. RGNX · Entity 2211 | GiftCommon Stock | 225,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-025725 · doc4.xml · nonDerivative · entry 2 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By The Harriette B. Fox Revocable Trust Disclosed balance after: 225,000 F2 · ownership.nature: This transaction involved a gift of shares of common stock held by The Allan M. Fox Revocable Trust to The Harriette B. Fox Revocable Trust, a revocable trust established for the benefit of the reporting person's spouse. The shares subsequently were transferred to HBF Gift Trust LLC on August 6, 2020. The reporting person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| July 27, 2020 Filed Sep 18, 2020 20:37 UTC | REGENXBIO Inc. RGNX · Entity 2211 | GiftCommon Stock | 225,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-025725 · doc4.xml · nonDerivative · entry 1 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By The Allan M. Fox Revocable Trust Disclosed balance after: 1,414,110 F1 · ownership.nature: At the time of the transaction, the reporting person was a trustee of The Allan M. Fox Revocable Trust, which was the direct beneficial owner of the shares of the Issuer's common stock. The reporting person disclaims beneficial ownership of such shares. Such shares are now held by DING LLC. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 20:32 UTC | REGENXBIO Inc. RGNX · Entity 2211 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $37.66 | $0.00 |
DisclosureSEC source: 0001562180-20-004064 · primarydocument.xml · derivative · entry 1 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-05-29 F1 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 29, 2020. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 20:25 UTC | REGENXBIO Inc. RGNX · Entity 2211 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $43.02 | $0.00 |
DisclosureSEC source: 0001562180-19-003298 · primarydocument.xml · derivative · entry 1 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-05-31 F1 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 31, 2019. Read SEC document |
| May 25, 2018 Filed May 30, 2018 20:29 UTC | REGENXBIO Inc. RGNX · Entity 2211 | GrantStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $49.45 | $0.00 |
DisclosureSEC source: 0001562180-18-002715 · primarydocument.xml · derivative · entry 1 Fox Allan M. · CIK 0001652936 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2028-05-25 F1 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 25, 2018. Read SEC document |
| May 24, 2017 Filed May 26, 2017 21:00 UTC | REGENXBIO Inc. RGNX · Entity 2211 | GrantStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $18.85 | $0.00 |
DisclosureSEC source: 0000899243-17-014567 · doc4.xml · derivative · entry 1 Fox Allan M. · CIK 0001652936 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2027-05-24 F1 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 24, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.